CLINICAL_TRIALS
trial_result
· 2019-10-24
Clinical Trial Update: A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
Summary
A completed clinical trial evaluating the safety and efficacy of Enantone (leuprorelin) in Chinese participants with central precocious puberty.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Central Precocious Puberty | Status: COMPLETED | Results posted: 2019-10-24